Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Korean Red Ginseng for Central Blood Pressure in Hypertension
NCT02211352Phase 2Completed
- Sponsor
- Daegu Catholic University Medical Center
- Start
- May 2012
- Primary completion
- Dec 2013
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial (2 arms), sponsored by Daegu Catholic University Medical Center. Primary endpoint: central blood pressure change at 16 weeks. Started May 2012; status: completed.
Beyond the preview
Go deeper on NCT02211352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02211352.